Feed 6917.TWO
69
Andros Pharmaceuticals Co.,Ltd
6917.TWO · TWO
$31.90 -2.30% (-$0.75)
1M +3.87%
Market Cap $1.4B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$27.67
13.3% downside
Trenutna cena
$31.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 6917.TWO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Valuation
30 /100
Expensive P/S 6,684.39x
P/B 3.44x
P/E N/A
Growth
22 /100
Declining Rev. growth 75.20%
Book val. growth 79.06%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 4.93%
Net margin 38,561.10%
FCF margin 41,096.10%
Quality
0 /100
Poor ROIC 21.37%
ROA 17.73%
Asset turnover 0.00x
Debt
80 /100
Low Debt/Equity 0.06x
Current ratio 13.81x
Net debt/EBITDA 0.23x
Stability
47 /100
Moderate Beta 0.72x
Rev. volatility 17.28%
Profitable years 0
Vprašajte StockBota o 6917.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ming-Wen Lee
Employees
15
Headquarters
Zhubei